About
Technology
Issues
FAQ
Links
Official Page
Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.